A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine

Sars Cov-2, the pathogen which belongs to the beta coronavirus family that is responsible for COVID-19, uses Angiotensin Converting Enzyme 2 (ACE2) as a receptor, which is responsible for controlling the actions of renin-angiotensin system (RAS). Sars Cov-2 - ACE2 binding leads to a RAS mediated imm...

Descripción completa

Detalles Bibliográficos
Autor principal: Ozbalci, Demircan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168307/
https://www.ncbi.nlm.nih.gov/pubmed/34102600
http://dx.doi.org/10.1016/j.mehy.2021.110619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168307/
https://www.ncbi.nlm.nih.gov/pubmed/34102600
http://dx.doi.org/10.1016/j.mehy.2021.110619

Ejemplares similares